Skip to main content

Medicinova Inc

MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001226616

In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Medicinova Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of MNOV: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders33130−2
Shares4.79M694.9K4.93M+837.2K (+20.5%)
Value$7.04M$1.00M$10.4M+$4.32M (+71.4%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Medicinova Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to MNOV in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.700,578$1.47M0.00%
Jane Street Group, LLC14,138$29.7K0.00%
Goldman Sachs Group Inc10,246$21.5K0.00%
Buckingham Strategic Partners10,000$21.0K0.00%

Sold out (6)

Institutions that held Medicinova Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of MNOV in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Bank of Montreal132,230$337.2K
Advisor Group Holdings, Inc.2,500$3.60K
Mather Group, LLC.50$73
Qube Research & Technologies Ltd32$46
Royal Bank of Canada165$0
Simplex Trading, LLC52$0

Not filed for Q3 2024 yet (1)

Institutions that held Medicinova Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MNOV in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.694,943$1.00M